DR Healthcare is open to build strategic, solid and successful alliances with other companies and research and development institutions. The areas of connection are the research, development, innovation and licensing of products for the treatment, prevention and diagnosis of the DAO deficiency and all its associated pathologies.
In this way DR Healthcare and their allies join forces to continue generating innovation in order to improve the quality of life for people suffering from this metabolic syndrome.
- DR Healthcare is looking for strategic alliances with relevant partners in those territories where does not operate directly, with the objective of facilitating access to our solutions for treatment, prevention and diagnosis to the patient society of the DAO deficiency.
- We supply the finished product and ready for marketing in each territory, fulfilling the regulatory framework of each market and ensuring the highest quality standards.
- We endorse more than 12 years of experience in the implementation of win-win agreements in the biomedical field, sharing experience with our partners and offering support to ensure success.
- We identify and value licensing opportunities in the field of pathologies associated to DAO deficiency, whatever their state of development.